Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era.
about
Severe Acute Hepatitis B in HBV-Vaccinated Partner of a Patient with Multiple Myeloma Treated with Cyclophosphamide, Bortezomib, and Dexamethasone and Autologous Stem Cell Transplant.Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan.
P2860
Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents' era.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Incidence and clinical backgro ...... myeloma in novel agents' era.
@en
Incidence and clinical backgro ...... myeloma in novel agents' era.
@nl
type
label
Incidence and clinical backgro ...... myeloma in novel agents' era.
@en
Incidence and clinical backgro ...... myeloma in novel agents' era.
@nl
prefLabel
Incidence and clinical backgro ...... myeloma in novel agents' era.
@en
Incidence and clinical backgro ...... myeloma in novel agents' era.
@nl
P2093
P2860
P1433
P1476
Incidence and clinical backgro ...... e myeloma in novel agents' era
@en
P2093
Atsushi Isoda
Hideto Tamura
Hiroki Sugimori
Hiromi Koiso
Hiroshi Handa
Junji Tanaka
Maki Asahi
Makoto Sasaki
Masao Hagihara
P2860
P304
P356
10.1007/S00277-016-2742-7
P577
2016-06-30T00:00:00Z